Curium partners with ILL and NRG for long-term irradiation services to supply lutetium-177 for 100,000+ critically ill patients.

Curium, a nuclear medicine leader, partners with Institut Laue-Langevin (ILL) for long-term irradiation services at their high-flux reactor in Grenoble, France. This partnership adds to Curium's existing partnership with NRG I PALLAS in the Netherlands. The agreement aims to ensure continuous supply of lutetium-177 (Lu-177) to benefit over 100,000 critically ill patients worldwide within the next 5 years.

June 05, 2024
3 Articles